Vasoreactivity in Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension - A Case of Robust Response to Inhaled Nitric Oxide (iNO)

被引：0
|
作者：
Seth, R. [1 ]
Atchley, W. T. [2 ]
Brewer, S. [1 ]
机构：
[1] Univ Arkansas Med Sci, Internal Med, Little Rock, AR USA
[2] Univ Arkansas Med Sci, Pulm & Crit Care Med, Little Rock, AR USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2229
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Inhaled Treprostinil in Pulmonary Hypertension Associated with Lung Disease
    Faria-Urbina, Mariana
    Oliveira, Rudolf K. F.
    Agarwal, Manyoo
    Waxman, Aaron B.
    LUNG, 2018, 196 (02) : 139 - 146
  • [32] DOSE RESPONSE ANALYSIS OF INHALED TREPROSTINIL IN PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE AND ITS EFFECTS ON CLINICAL WORSENING
    Waxman, Aaron
    Nathan, Steven
    Fisher, Micah
    Ford, H. James
    Gagermeier, James
    Parambil, Joseph
    Raina, Amresh
    Zwicke, Dianne
    Gerke, Alicia
    Shen, Eric
    Lee, Dasom
    Rao, Youlan
    Tapson, Victor
    CHEST, 2021, 160 (04) : 2279A - 2280A
  • [33] Acute vasoreactivity testing for severe pulmonary hypertension associated with lung disease
    Takano, R.
    Fujisaki, S.
    Endo, H.
    Nishi, N.
    Hayashi, H.
    Kiko, T.
    Asano, R.
    Ueda, J.
    Aoki, T.
    Tsuji, A.
    Ogo, T.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [34] Acute vasoreactivity testing for severe pulmonary hypertension associated with lung disease
    Takano, R.
    Fujisaki, S.
    Endo, H.
    Nishi, N.
    Hayashi, H.
    Kiko, T.
    Asano, R.
    Ueda, J.
    Aoki, T.
    Tsuji, A.
    Ogo, T.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [35] What definition of vasoreactivity to inhaled nitric oxide best predicts mortality risk in patients with pulmonary hypertension?
    Krasuski, RA
    Smith, B
    Wang, A
    Harrison, JK
    Johnson, M
    Pierce, C
    Tapson, VF
    Bashore, TM
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 411A - 411A
  • [36] Pharmacogenomics of inhaled nitric oxide response in persistent pulmonary hypertension of the newborn
    Ford, S
    Leeder, S
    Gaedigk, A
    Truog, W
    PEDIATRIC RESEARCH, 2004, 55 (04) : 471A - 471A
  • [37] Response to Inhaled Nitric Oxide Predicts Survival in Patients With Pulmonary Hypertension
    Krasuski, Richard A.
    Devendra, Ganesh P.
    Hart, Stephen A.
    Wang, Andrew
    Harrison, J. Kevin
    Bashore, Thomas M.
    JOURNAL OF CARDIAC FAILURE, 2011, 17 (04) : 265 - 271
  • [38] A Case of Interstitial Lung Disease-Related Pulmonary Hypertension Successfully Treated with Inhaled Iloprost
    Jang, Ji Hoon
    Jang, Hang-Jea
    Lee, Jae Ha
    LIFE-BASEL, 2024, 14 (09):
  • [39] Inhaled Nitric Oxide Response in Various Types of Congenital Heart Disease with Pulmonary Hypertension 123
    John P Kovalchin
    Antonio R Mott
    Kerry L Rosen
    Timothy F Feltes
    Pediatric Research, 1998, 43 (Suppl 4) : 24 - 24
  • [40] Response to "Noninvasive determinants of pulmonary hypertension (PH) in interstitial lung disease (ILD)" by Joseph et al.
    Parikh, Raj
    Farber, Harrison W.
    PULMONARY CIRCULATION, 2023, 13 (02)
12345